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Nonischemic Cardiomyopathy and Ventricular Tachycardia. Background: In patients with
prior infarction, isolated potentials (IPs) during sinus rhythm reflect fixed scar and often indicate sites
critical for ventricular tachycardia (VT). The purpose of this study was to determine the value of IPs
in conjunction with pace-mapping to guide VT ablation in patients with various types of nonischemic
cardiomyopathy.
Methods: Mapping and ablation of VT were performed in 35 consecutive patients (26 men, age 55 ±
13 years, ejection fraction 0.31 ± 0.14) with VT and various etiologies of nonischemic cardiomyopathy.
Pace-mapping was performed at sites with low voltage. Radiofrequency energy was delivered at sites with
concealed entrainment or matching pace-maps.
Results: One hundred ninety-five VTs (mean cycle length 363 ± 88 ms) were induced. Sites with pre-
specified ablation criteria displaying IPs during sinus rhythm were recorded in 21 of 35 patients (60%,
IP-positive). In these patients, a total of 216 sites meeting prespecified ablation criteria were identified and
146 of 216 sites (68%) displayed IPs. Fifteen of 21 IP-positive patients (71%) no longer had inducible VT
after ablation. In 14 of 35 patients, no sites with IPs where prespecified ablation criteria were met were
identified (IP-negative) despite combined endocardial and epicardial mapping in 7 of 14 patients. Only 1
of 14 IP-negative patients (7%) no longer had inducible VT at the end of the ablation procedure. During a
mean follow-up of 18 ± 13 months, 14 of 21 IP-positive patients (67%) remained arrhythmia-free, compared
to 1 of 14 IP-negative patients (7%; P < 0.01). Half of the IP-negative patients had major adverse events
due to recurrent arrhythmias, compared to none in IP-positive patients.
Conclusion: IPs in conjunction with pace-mapping are helpful for identifying critical isthmus areas for
ablation of VT in patients with various types of nonischemic cardiomyopathy. Patients with nonischemic
cardiomyopathy in whom the arrhythmogenic substrate is characterized by IPs have a more favorable
outcome than patients in whom IPs are absent. (J Cardiovasc Electrophysiol, Vol. 21, pp. 1017-1023, September
2010)
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cardia
Introduction
Isolated potentials (IPs) during sinus rhythm indicate ar-
eas of fixed scar in patients with previous myocardial infarc-
tion.1 In addition to pace-mapping, which has been used to
identify exit sites of reentry circuits,2 IPs have been found
to be helpful in guiding radiofrequency catheter ablation of
ventricular tachycardia (VT) in postinfarction patients.3 Lo-
calized areas of myocardial fibrosis resulting in electrogram
fragmentation are frequently found and may represent the
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anatomic substrate for VT in patients with nonischemic car-
diomyopathy.4
The purpose of this study was to assess the value of IPs
during sinus rhythm in conjunction with pace-mapping for
identifying potential target sites for VT ablation in patients
with various types of nonischemic cardiomyopathy.
Methods
Patient Characteristics (Table 1)
The subjects of this study were 35 consecutive patients
(26 males, age 55 ± 13 years, ejection fraction 0.31 ± 0.14
[mean ± 1 standard deviation]) with nonischemic cardiomy-
opathy who were referred for mapping and ablation of VT.
In 30 patients, the indication for VT ablation was recurrent
implantable cardioverter–defibrillator (ICD) shocks. Seven
patients (20%) had cardiac sarcoidosis, 4 patients had ar-
rhythmogenic right ventricular dysplasia (ARVD) (11%),
and the remainder had idiopathic dilated cardiomyopathy
(69%). Twelve-lead ECGs of the clinical VT were available
in 16 of 35 patients. All patients had failed antiarrhythmic
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TABLE 1
Patient Characteristics
Total number of patients 35
Age (years) 55 ± 13
Male (no. %) 26 (74%)
LVEF (%) 31 ± 13
Idiopathic DCM (%) 24 (68%)
Sarcoid heart disease (%) 7 (21%)
ARVD (%) 4 (11%)
ARVD = arrhythmogenic right ventricular dysplasia; DCM = dilated
cardiomyopathy; LVEF = left ventricular ejection fraction.
treatment including amiodarone in 14 patients. Thirty pa-
tients (86%) had an ICD. Three patients underwent ICD im-
plantation after the ablation procedure. Two patients refused
ICD implantation.
A total of 195 VTs were inducible by programmed ven-
tricular stimulation. The mean VT cycle length was 363 ±
88 ms. Ninety-six of the VTs (49%) had a left bundle branch
block morphology and 99 (51%) had a right bundle branch
block morphology. None of the VTs was due to bundle branch
reentry.
Electrophysiologic Study
This study was approved by the University of Michigan
Institutional Review Board. After informed consent was ob-
tained, vascular access was obtained in a femoral vein. Two
multielectrode catheters were positioned in the His position
and the right ventricular apex. Programmed ventricular stim-
ulation from at least 2 right ventricular sites was performed
using up to 4 extrastimuli before and after the ablation pro-
cedure.5 Three thousand units of heparin was administered
followed by an additional 1,000 units per hour for right-sided
procedures. For left ventricular procedures an activated clot-
ting time of >300 seconds was targeted.
For mapping and ablation an 8 French open irrigated-
tip catheter with a 3.5-mm-tip electrode (Thermocool R©;
Biosense Webster, Diamond Bar, CA, USA) was used in
conjunction with a 3-dimensional electroanatomic mapping
system (CARTO; Biosense Webster). In 8 patients, a 4-mm-
tip ablation catheter (Navistar; Biosense Webster) was used
for mapping and ablation. Intracardiac electrograms and sur-
face electrocardiograms were displayed on an oscilloscope
and recorded on optical disc (EP Med Systems Inc., West
Berlin, NJ, USA).
Mapping Procedure
Voltage maps were generated during sinus rhythm
(Fig. 1). An IP was defined as a distinct potential separated
from the ventricular electrogram by an isoelectric segment,
and/or a segment with low amplitude noise (<0.05 mV) of
>20 ms duration at a gain of 40–80 mm/mV (Fig. 2). Pace-
mapping was performed at sites with low voltage (<1.5 mV;
Fig. 2). Electrograms were assessed by 2 independent ob-
servers. Discrepancies were resolved by consensus. Repre-
sentative examples of IPs are shown in Figure 3.
A matching pace-map was defined as a pace-map in which
≥10/12 leads matched with the QRS morphology of the in-
duced VT.3
Hemodynamically tolerated VTs were mapped by entrain-
ment mapping. An isthmus site was defined as a site demon-
Figure 1. Electroanatomic bipolar voltage map of the right ventricle in
a patient with nonischemic cardiomyopathy (right anterior oblique view
with caudal tilt). Pulmonary artery (PA), tricuspid valve annulus (TVA),
and right ventricular apex are indicated. Large areas with low voltage are
present. The blue tag denotes the site of an isolated potential (IP) during
sinus rhythm (Fig. 2) and a matching pace-map for one of the patient’s VTs
(Fig. 3). The site was an effective ablation site for this VT.
strating concealed entrainment with matching stimulus-QRS
and electrogram-QRS intervals and VT termination during
ablation.
Pace-mapping was performed for nontolerated VTs at the
cycle length of the targeted VT. If multiple VTs were targeted,
pacing was performed at the mean cycle length of the targeted
VTs.
If multiple VTs were targeted, pacing was performed with
a cycle length averaging the targeted VTs. An isthmus area
Figure 2. Left panel: An IP (arrow) recorded with the distal electrodes
of the mapping catheter (Map dist) at the right ventricular site shown in
Figure 1. The IP has an amplitude of 0.23 mV and is separated from the
ventricular electrogram by 50 ms. Middle panel: Twelve-lead ECG showing
VT at a cycle length of 280 ms, with a left bundle branch block morphology
and superior axis (left). Right panel: Pacing from the right ventricular site
shown in Figure 1 resulted in a matching pace-map (right).
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Figure 3. IPs (arrows) recorded by the mapping catheter (Map) in various types of cardiomyopathy. Panel A shows IPs in a patient with dilated cardiomy-
opathy, panel B shows an example of IPs in a patient with cardiac sarcoidosis, and panel C shows IPs in a patient with arrhythmogenic right ventricular
cardiomyopathy.
was defined as an area where there was a matching pace-map
and noninducibility of the targeted VT after the ablation. The
prespecified criteria for delivery of radiofrequency energy
were the presence of concealed entrainment (Fig. 4) or the
presence of matching pace-maps. IPs were noted but were not
by themselves a criterion to deliver radiofrequency energy.
Radiofrequency Ablation
Radiofrequency energy was delivered if prespecified cri-
teria were present. All inducible VTs were targeted. If these
criteria were present in the vicinity of an anatomical barrier
(tricuspid, mitral, pulmonary, or aortic annulus), the ablation
lesion was continued to the annulus as long as this region
displayed low voltage. Otherwise, ablation was delivered at
sites with matching pace-maps.
The endpoint of the procedure was noninducibility of all
inducible VTs for which an isthmus was identified. Pro-
Figure 4. Concealed entrainment in a patient with nonischemic cardiomy-
opathy.
grammed stimulation was repeated after the ablation proce-
dure from 2 right ventricular sites with up to 4 extrastimuli.
Radiofrequency ablation was performed using a Stockert
RF generator (Biosense Webster). Radiofrequency energy
was delivered for 60–120 seconds at an initial output of
35 W and/or until the capture threshold post-ablation was
>10 mA. Power was titrated to achieve a 10 ohms impedance
drop; maximal temperature was set to 45◦C for irrigated tip
catheters. For nonirrigated catheters, the target temperature
was set to 60◦C at a power of 30–70 W.
Data Analysis
Patients in whom IPs were recorded during elec-
troanatomic mapping (IP-positive) were compared to patients
in whom no IPs were recorded (IP-negative). In 7 of 14 pa-
tients in whom no IPs were recorded during endocardial
mapping, transcutaneous epicardial mapping (n = 4) or lim-
ited epicardial mapping through the coronary venous system
(n = 3) also failed to identify sites displaying IPs. A mean of
356 ± 237 points/patient were registered during the baseline
rhythm (331 ± 222 points in IP-positive patients compared to
392 ± 262 points in IP-negative patients; P = 0.5). Measure-
ments of electrogram amplitude and width were performed
with electronic calipers. If an IP was present, the total width
of the electrogram was measured from the onset of the elec-
trogram to the end of the IP. Also the interval from the end
of the QRS complex to the IP was measured.
Histology
In 2 patients in whom no IPs were recorded during left and
right ventricular endocardial and epicardial mapping, cardiac
transplantation was performed for uncontrolled VT 14 and 26
days after the ablation procedure. Samples of myocardium
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were procured from the septum, anterior wall, and lateral
wall of the left ventricle, midway between the apex and base.
Tissue samples also were procured from ablation sites and
sites immediately adjacent to the ablation lesions. The tissue
sections were stained with hematoxylin/eosin and trichrome
stains.
Statistical Analysis
Continuous variables are expressed as mean ± 1 standard
deviation. Comparisons were performed using Student’s t-
test. Discrete variables were compared using chi-square test
or the Fisher exact test, as appropriate. A P-value of <0.05
indicated statistical significance.
Follow-up
The patients were followed every 3–6 months in the ICD
clinic to assess for VT recurrences. Major adverse events
were defined as death, implantation of a left ventricular assist
device, or cardiac transplantation.
Results
One hundred ninety-five VTs (mean cycle length 363 ±
88 ms) were induced. None of the VTs were due to bun-
dle branch reentry. A total of 882 distinct sites where pace-
mapping was performed were analyzed. The mean electro-
gram amplitude at these sites was 0.67 ± 0.77 mV, with a
mean width of 139 ± 96 ms. IPs were identified in 21 of
35 patients (IP-positive) at 213 of 882 sites (24%). In 39%
of the sites with IPs, the electrogram extended beyond the
end of the QRS complex. IP-positive patients had a mean of
5.3 ± 5.2 (range 1–22) inducible VTs. In 14 of 35 patients
(IP-negative), no IPs were identified despite extensive map-
ping, including epicardial mapping in 7 of the 14 patients.
IP-negative patients had a mean of 6.0 ± 4.5 (range: 1–13)
inducible VTs.
Ablation Sites
All inducible VTs were targeted for ablation. Forty-two of
the VTs were hemodynamically tolerated and 17 VTs were
mapped with entrainment mapping. Three hundred thirteen
sites meeting the prespecified ablation criteria were identified
for 84/195 VTs (43%). After ablation, 144 of 195 VTs (74%)
were no longer inducible. Sixteen of 35 patients (46%) no
longer had inducible VT at the end of the ablation procedure.
Sites meeting prespecified ablation criteria were identified by
pace-mapping in 73 of 84 VTs and by entrainment mapping in
11 of 84 VTs. Acute efficacy was similar when an irrigated tip
catheter was used (n = 27) compared to when a nonirrigated
catheter (n = 8) was used (P = 0.7).
Isolated Potentials and Pace-Mapping (Table 2)
IPs were present more frequently at sites with matching
pace-maps than at sites with inadequate pace-maps (P <
0.0001). Sixty-nine percent of the sites displaying IPs had
matching pace-maps; on the other hand, pacing at sites with
low voltage alone, in the absence of IPs, less often showed
matching pace-maps (26%; P < 0.0001). The mean electro-
gram width and the stimulus-QRS interval were longer and
the electrogram amplitude was smaller at sites with IPs com-
pared to sites where IPs were absent. IPs extended 124 ±
133 ms beyond the end of the QRS complex. The presence
TABLE 2
Comparison of Sites With and Without Isolated Potentials
IP Present IP Absent P-Value
No. of evaluated sites 213 669 –
Amplitude (mV) 0.45 ± 0.71 0.74 ± 0.77 <0.0001
Electrogram width (ms) 254 ± 136 103 ± 28 <0.0001
S-QRS (ms) 91 ± 44 48 ± 21 <0.0001
Matching pace-map (%) 146/213 (69%) 175/669 (26%) <0.0001
IP = isolated potentials; S-QRS = stimulus-QRS interval.
of IPs during VT was associated with the presence of IPs. In
7 of 21 IP+ patients, a total of 10 sites were assessed during
baseline rhythm and during VT and 9 of 10 sites had IPs
during VT and during baseline rhythm.
Ablation and Relation to Isolated Potentials (Tables 2
and 3)
In 21 of 35 patients (60%), IPs were present at sites where
ablation criteria were met (IP-positive patients). In this group,
111 VTs were inducible (5.3 ± 5.2 VTs per patient). At least
1 site where the prespecified ablation criteria were met was
identified in each of the 21 patients. Table 3 compares electro-
physiologic characteristics in patients with and without IPs.
In 1 of 21 patients, no site with IPs and no site where ablation
criteria were met could be identified endocardially; transcuta-
neous epicardial mapping demonstrated 3 distinct epicardial
sites with IPs and all 3 VTs were eliminated by ablation. In 2
other patients, limited epicardial mapping through the coro-
nary venous system revealed areas with IPs that also were
critical to the VT in both patients. Both patients had a single
inducible VT that was effectively ablated within the great
cardiac vein.
In the 21 IP-positive patients, prespecified ablation criteria
were met at 216 sites for 62 of 111 VTs (56%); 146 of 216
sites (68%) displayed IPs. After ablation, 94 of 111 VTs
(85%) were no longer inducible. A total of 15 of 21 IP-
positive patients (71%) with IPs had no inducible VT at
TABLE 3
Characteristics of Patients With and Without Isolated Potentials
IP-Positive IP-Negative
Patients Patients
(n = 21) (n = 14) P-value
Points sampled per patient 331 ± 222 392 ± 262 0.48
Paced sites (total) 449 433
Induced VT morphology 55/56 41/43 0.9
(LBBB/RBBB)
Idiopathic DCM (n) 11 13 0.02
Sarcoid heart disease (n) 6 1 0.2
ARVD (n) 4 0 0.13
Number of VTs 5.3 ± 5.2 6.0 ± 4.5 0.68
Amplitude (mV) 0.64 ± 0.86 0.70 ± 0.66 0.17
Electrogram width (ms) 174 ± 122 103 ± 27 <0.0001
S-QRS (ms) 69 ± 40 47 ± 20 <0.0001
IP amplitude (mV) 0.18 ± 0.23 – –
IP separation (ms) 111 ± 111 – –
Matching pace-map (%) 216/449 (48%) 97/433 (22%) <0.0001
ARVD = arrhythmogenic right ventricular dysplasia; DCM = dilated car-
diomyopathy; LBBB = left bundle branch block morphology; RBBB =
right bundle branch block morphology; VT = ventricular tachycardia.
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the end of the procedure. All VTs with a matching pace-
map were no longer inducible after ablation. The presence
of IPs was associated with successful ablation even when
the patients with ARVD or sarcoidosis were excluded (P <
0.0001).
In the 14 IP-negative patients, 84 VTs were inducible
(6.0 ± 4.5 VTs per patient). Four of these patients underwent
transcutaneous epicardial mapping because no sites where
ablation criteria were met could be identified endocardially;
in 3 patients, the coronary venous system was mapped and the
effective ablation site was identified in the great cardiac vein
in one of the 3 patients. No IPs were recorded by epicardial
mapping in any of the 7 patients (50% of IP-negative patients)
who underwent epicardal mapping. Fifteen epicardial sites
met prespecified ablation criteria and resulted in ablation of 5
VTs. Despite extensive mapping including right ventricular,
left ventricular and transcutaneous epicardial mapping, no
IPs were recorded in the 4 patients who had a combined
endocardial and epicardial approach. In IP-negative patients,
a transcutaneous epicardial approach was used more often
(n = 4) compared to IP-positive patients (n = 1; P = 0.1).
In the 14 IP-negative patients, 97 sites where prespecified
ablation criteria were met were identified for 26 of 84 induced
VTs (31%). Despite matching pace-maps, only 21 of 26 VTs
were effectively ablated. Only 1 of 14 patients (7%) had no
inducible VT at the end of the ablation procedure.
Linear ablation lesions were part of the ablation lesions
in 12 patients due to the proximity to an annulus of the sites
where ablation criteria were met. The presence or absence
of a linear lesion was not associated with the inducibility
of VT after ablation (5 of 12 patients with a linear lesion
had inducible VT at the end of the procedure, whereas 7 of
12 patients with a linear lesion had an acutely successful
outcome; P = 0.4).
The mean procedure time was 375 ± 100 minutes (IP-
positive patients: 395 ± 122 minutes, IP-negative patients
349 ± 57 minutes; P = 0.2), and the mean fluoroscopy time
was 64 ± 45 minutes (IP-positive patients: 64 ± 26 minutes,
IP-negative patients: 64 ± 23 minutes; P = 0.99). A mean of
41 ± 32 minutes of radiofrequency energy were delivered per
patient (IP-positive patients: 50 ± 37 minutes, IP-negative
30 ± 21 minutes; P = 0.06).
Anatomic Distribution of Isolated Potentials
and Assessment of Low-Voltage Areas
IPs were located in low-voltage areas. The majority
(159/213 sites) of IPs were located in a low-voltage area
<0.5 mV; the remaining 54 sites were in a low voltage area of
0.5–1.5 mV. The endocardial low-voltage area in IP-positive
patients was 64 ± 52 cm2; in IP-negative patients, it was 71 ±
59 cm2 (P = 0.8). In patients with epicardial procedures, the
area of low voltage was greater in the epicardium than in
the endocardium (67 ± 52 cm2 compared to 160 ± 49 cm2;
P = 0.02). The low-voltage area was periannular in 16 of
21 IP-positive patients and in 12 of 14 IP-negative patients
(P = 0.9). Additional areas of low voltage that were not con-
tinuous with periannular low-voltage areas were present in
14 of 21 IP-positive and 12 of 14 IP-negative patients (P =
0.2). The IPs were right ventricular, including the peritricus-
pid area and the right ventricular outflow tract, in all patients
with ARVD. In patients with cardiac sarcoidosis with VTs
originating in the right ventricle, IPs were located in the per-
itricuspid area in all 7 patients and in the right ventricular
outflow tract in 3 of 7 patients. In patients with dilated car-
diomyopathy, IPs were located in the periannular area in 11
of 24 patients. In 1 of 5 patients in whom both endocardial
and epicardial mapping was performed, IPs were identified
in the epicardial lateral LV free wall.
Histology (Fig. 5)
The left ventricular tissue samples showed a diffuse pat-
tern of fibrosis. There was widespread fibrosis characterized
by patches of fibrotic tissue, frequently anastomosing with
fine extension from other patches, and surrounding bundles
of myocytes. This pattern often merged into areas of diffuse
fibrosis. These same patterns of fibrosis were present im-
mediately adjacent to sites of pace-guided ablation. Despite
the widespread interstitial fibrosis, the overall myocyte fiber
orientation was uninterrupted. Ablation sites were necrotic,
with organization along their periphery. The histologic find-
ings were similar in both patients in whom samples were
obtained.
Follow-Up
The mean follow-up duration was 18 ± 13 months. There
was no difference in mortality between the 2 groups. Major
adverse events occurred more frequently in IP-negative pa-
tients (n = 7: 50%) than in IP-positive patients (n = 2: 10%;
P = 0.01). All events except one were related to VT/VF in
IP-negative patients: VT resulting in death (n = 1) and VT
storm (n = 4), and VF (n = 1) resulting in placement of
left ventricular assist device or heart transplantation (n =
5). One patient died from heart failure 4 days after an ab-
lation procedure. This patient required intravenous inotropic
agents before the ablation procedure and continued to require
inotropic agents after the ablation procedure. One death oc-
curred in the IP-positive patients 17 months after an effective
ablation procedure due to heart failure; this patient did not
have any VT after ablation. One other IP-positive patient un-
derwent cardiac transplantation for worsening heart failure.
No VT-related adverse events occurred in the IP-positive pa-
tients. No other adverse events occurred during or after the
ablation procedure.
During follow-up, treatment with antiarrhythmic medi-
cations was continued in 11 of 21 IP-positive patients. The
remaining 10 IP-positive patients were not treated with an-
tiarrhythmic medications during follow-up. Treatment with
antiarrhythmic medications was continued in all but 2 IP-
negative patients, and in 3 of these patients, another antiar-
rhythmic medication was added to the pre-ablation drug reg-
imen. IP-positive patients were less likely to be treated with
amiodarone (8/21 IP-positive patients vs. 12/14 IP-negative
patients; P = 0.01) and were less likely to be treated with
combination therapy (2/21 IP-positive patients compared to
8/14 IP-negative patients; P = 0.002).
Two of the IP-positive patients who became noninducible
after ablation refused ICD implantation. All but 1 IP-positive
patient who had no inducible VT after the ablation procedure
(n = 15) remained free of VT during follow-up. This patient
required a repeated ablation procedure. Only 1 of 14 IP-
negative patients (7%) remained free of VT during follow-
up. This patient had been rendered noninducible at the end
of the ablation procedure.
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Figure 5. Left ventricular myocardium from the mid-lateral wall in a patient who underwent heart transplantation after a failed ablation procedure. There
was no visible scarring at the endocardial site where the tissue was sampled. No IPs were found in this patient during endocardial and epicardial mapping.
The tissue sample shows compact patches of fibrosis anastomosing and merging into more diffuse fibrosis. The sample is representative of the other sampled
sites (Masson trichrome stain, 40×). An insert of the voltage map (top left) displays the endocardial voltage of this patient (low voltage [<1.5 mV] is
indicated in red color). Left ventricular apex, mitral valve annulus (MVA), and aorta are indicated.
The mean number of appropriate ICD therapies decreased
from 47 ± 72 in the 3 months before the ablation procedure
to 7 ± 14 during the first 3 months of follow-up (P = 0.005)
and to 14 ± 27 during a mean of 18 ± 13 months of follow-
up (P = 0.005). There was no significant difference in the
number of ICD therapies in IP-positive patients compared
to IP-negative patients in the 3 months before the ablation
procedure (P = 0.1). ICD therapies after ablation decreased




This study demonstrates that IPs in patients with nonis-
chemic cardiomyopathy identify critical sites for ablation of
VT. IPs are not identifiable in all patients with nonischemic
cardiomyopathy and the presence of IPs identifies a subgroup
TABLE 4
Prevalence of Appropriate Defibrillator Therapies Before and After the
ICD Therapies in Patients With and Without Isolated Potentials
IP-Positive IP-Negative
ICD Therapies (n) (n = 21) (n = 14) P-Value
3 months before ablation 28 ± 35 70 ± 97 0.11
3 months after ablation 0.2 ± 0.5∗ 16 ± 18 0.0007
Total after ablation 0.7 ± 1.7† 32 ± 34 0.0003
∗P = 0.007 in IP-positive patients before ablation compared to 3 months
postablation. †P = 0.007 in IP-positive patients before ablation compared
to the total follow-up period. ICD = implantable cardioverter defibrillator.
with a favorable short- and mid-term prognosis after catheter
ablation.
Electrophysiologic Characteristics of Anatomic Substrate
in IP-Positive Patients
Patients with various types of nonischemic cardiomyop-
athy are described in this study, with the most common
type being idiopathic dilated cardiomyopathy. Regardless
of the type of cardiomyopathy, the presence of IPs ap-
pears to identify a subgroup of patients with a favor-
able prognosis. IPs were not present to the same ex-
tent in all forms of nonischemic cardiomyopathy. They
were identified in all patients with ARVD and most pa-
tients with cardiac sarcoidosis but not in all patients
with dilated cardiomyopathy. Although large areas of scar
are uncommon in patients with nonischemic cardiomyop-
athy, extensive interstitial fibrosis is frequently seen histo-
logically.4 Strands of fibrous tissue may serve as electrical
barriers and result in electrogram fragmentation. The degree
of fibrosis6 as well as the fiber orientation relative to the loca-
tion of fibrotic barriers may be factors resulting in activation
delay and electrogram fragmentation.7
In patients with idiopathic dilated cardiomyopathy, vari-
able patterns of fibrosis have been described.6,7 It appears
that some patients with nonischemic cardiomyopathy have a
characteristic pattern of fibrosis that results in specific elec-
trophysiologic properties. A corresponding electrogram pat-
tern with multiple spikes separated by isoelectric segments
has been described in patients with a high degree of fibrosis
that has been characterized as replacement fibrosis,6 similar
to postinfarction scars. As in postinfarction patients, critical
areas often display IPs and the presence of IPs is a bet-
ter marker for critical areas than low-voltage alone. These
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areas often are areas of slow conduction where block can oc-
cur.6,8 The presence of a fixed area of block indicates that the
arrhythmogenic substrate is confined to a circumscribed area
determined by the scar and therefore may be amenable to
focal ablation lesions.
Electrophysiologic Characteristics of the Anatomic
Substrate in IP-Negative Patients
In patients without IPs, although matching pace-maps
were present, the outcomes after catheter ablation were less
favorable than in patients in whom IPs were present. The
diffuse pattern of fibrosis that was found histologically in 2
patients undergoing cardiac transplantation is similar to the
pattern of moderate fibrosis described by Anderson et al. in
some of patients with cardiomyopathy, in which the fibrosis
did not interrupt myocyte fiber orientation.6 In these 2 pa-
tients, no IPs were identified despite extensive endocardial
and epicardial mapping. It is possible that in the presence of
moderate fibrosis, the exit site of a reentrant circuit may be
less fixed and may more often be determined by functional
lines of block.
Prognostic Implications
Similar to patients with ischemic cardiomyopathy, pa-
tients in whom no sites with IPs were identified during map-
ping of VT had a high probability of recurrent VT.3 Major
complications associated with the failure to eliminate in-
ducible VTs by ablation have been described previously in
patients with nonischemic cardiomyopathy.9-11 It is possi-
ble that systematic epicardial mapping in all patients would
have revealed IPs in some of the patients who did not have
endocardial IPs. However, among the 7 patients with major
arrhythmic events during follow-up, 3 patients had under-
gone percutaneous epicardial mapping and 1 had undergone
limited epicardial mapping from the coronary venous system
without detecting IPs. A possible explanation for the failure
of catheter ablation is that the reentry circuits were less often
anatomically fixed when IPs were absent.
Prior Reports
Soejima et al.,12 Delacratez et al.,13 and Cano et al.14
reported data on mapping and ablation in patients with non-
ischemic cardiomyopathy. The value of IPs however and
possible prognostic implications were not assessed.
Limitations
A limitation of this study is that epicardial mapping was
performed in only approximately one-third of patients who
did not have endocardial IPs. A second limitation is that pac-
ing from other ventricular locations, which may reveal late
local activity that may not be recorded in sinus rhythm, was
not performed in our study. Therefore, the prevalence of IPs
in nonischemic cardiomyopathy may have been underesti-
mated. Finally, histological samples were available only from
IP-negative patients. Histological samples from IP-positive
patients would have facilitated a comparison of the structural
basis for the presence or absence of IPs.
Conclusion
IPs in conjunction with pace-mapping indicate critical ar-
eas of VT circuits in patients with nonischemic cardiomyop-
athy. Freedom from VT can be achieved by catheter ablation
in most patients in whom IPs are detected during mapping of
VT. Patients in whom IPs are present at critical ablation sites
appear to have a better prognosis and fewer major adverse
events than patients in whom the arrhythmogenic substrate
is not characterized by IPs.
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